Iodine-125 interstitial brachytherapy for malignant tmnor

Objective To assess the clinical effects of 125 I interstitial brachytherapy for malignant tumors. Methods One hundred and twelve patients with malignant tumors of stage Ⅱ stage and Ⅲ under went radical resection combined with 125 I intraoperative implantation. Seven days and three months effter operation WBC count and immune markers were observed. Blood biochemistry ultrasonography and X-ray were performed to observe recurrence and metastasis of tumors per three months. Results In the 112 patients, 3 died of tumor recurrence in six months, and others survived with the longest time of 35months. Conclusion 125 I interstitial brachytherapy for malignant tumor is simple,safe and effective. 2 refs,2 tabs.